ArticleClinical and experimental medicine2024

Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.

Fulvia Ceccarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.